Sanofi Extends $69-Per-Share Tender Offer For Genzyme To Jan. 21
This article was originally published in The Pink Sheet Daily
Executive Summary
Less than 1% of outstanding shares had been tendered as of Dec. 10 deadline.
You may also be interested in...
Sanofi And Genzyme Move Closer To A Deal
Companies enter confidentiality agreement allowing Sanofi to conduct due diligence and reportedly have agreed on outlines of a deal.
Sanofi And Genzyme Move Closer To A Deal
Companies enter confidentiality agreement allowing Sanofi to conduct due diligence and reportedly have agreed on outlines of a deal.
Genzyme Builds New Manufacturing Facility As Takeover Deadline Approaches
Belgium-based plant will be used to manufacture Myozyme and Lumizyme for Pompe disease, a franchise that Genzyme says has the potential to become a blockbuster.